A biotechnology company, Avalo Therapeutics, Inc. (Nasdaq: AVTX), headquartered in Wayne, Pennsylvania, specializing in therapeutics for immune-mediated inflammatory diseases, revealed that it is set to join the small-cap Russell 2000® Index and the broad-market Russell 3000® Index. This change will come into effect after the closure of U.S. stock markets on June 26, 2026.